πŸ‡ΊπŸ‡Έ FDA
Patent

US 11999727

Compounds and methods of use

granted A61KA61K31/4545A61K31/4709

Quick answer

US patent 11999727 (Compounds and methods of use) held by Tango Therapeutics, Inc. expires Mon May 30 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Tango Therapeutics, Inc.
Grant date
Tue Jun 04 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 30 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
30
CPC classes
A61K, A61K31/4545, A61K31/4709, A61K31/4725, A61K31/496